Plenary Lecture

Choi-Fong Cho, PhD

Assistant Professor of Neurosurgery, Harvard University

Blood-Brain-Barrier Assembloids for Modeling Therapeutic Delivery to Brain Tumors

 Paresh Chothe, PhD

Associate Principal Scientist, AstraZeneca

Predicting Oral Absorption, Intestinal Availability, CYP3A4 Induction and Transporter-mediated DDI Using Human Primary Intestinal 3D Model (EpiIntesinal^TM)

James Gosset, BSc.

DMPK Associate Research Fellow @ Pfizer

liver tissue chip platform- Title TBA

Eshita Khera, PhD

Principal Scientist II @ Novartis

Harnessing in vitro and Bioanalytical Data for Quantitative Systems Pharmacology (QSP) Modeling of Antibody-Drug Conjugates

 Brian Ogilvie, PhD

VP of Scientific Consulting @ BioIVT

Highlights From the Final ICH M12 Guideline "Drug Interaction Studies" - What's Changed and Considerations for Your IND Programs

Cinthia Pastuskovas, PhD

Principal Scientist @ Denali Therapeutics

Disposition of Novel Brain-Penetrant Therapeutics

Jason Pennucci

Director Bioanalytical Sciences @ Moderna Therapeutics

Title TBA

Nadia Terranova, PhD, EMBA

Head of QP Advanced Data Analytics @ EMD Serono (Merck KGaA)

AI/ML for Model-Informed Precision Medicine

Jaydeep Yadav, PhD

Associate Principal Scientist @ Merck

Strategies and Approaches for Modeling and Prediction of Large Molecule Drug-Drug Interactions 

Matt Silva, PhD

CEO @ Emit Imaging

Cryo-Fluorescence Tomography: Transformative 3D Imaging to Monitor Drug PK/PD

 Steven Louie, PhD

Director of DMPK @ Medicilon U.S.

Advancing siRNA form Discovery Target to Preclinical Candidate

 Erik Willems, PhD

Director of Scientific Operations @ Discovery Life Sciences

Applications of Cryopreserved Plateable Mouse Hepatocytes in Drug Metabolism and Gene Regulation Discovery Studies